ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

NCI Gets Out of the News Business

January 25, 2013

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977